Up until recently, as far as sales and marketing platforms go, Infusionsoft has been a fairly well-kept secret. Yet, two weeks ago, the company landed $54 million in series C financing from Goldman Sachs, bringing its total funding to $71 million. With this new infusion of capital, the makers of a growing, SaaS sales and marketing automation platform for small businesses are now on track for a potential IPO in the next few years. In his interview with Alex Williams, Infusionsoft CEO Clate Mask said that the team is building “a big, independent company that we hope will be around for decades to come … we want to be the Intuit for the sales and marketing business of a company.”

Today, it’s also become clear that, as a part of that mission, Infusionsoft has been on the hunt for potential acquisitions that will help it meet the growing demand for…

View original post 632 more words


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s